Kwality Pharmaceuticals Ltd.

BSE: 539997 SECTOR: Pharmaceuticals & Drugs  7327   65   2

948.35
-49.90 (-5.00%)
BSE: Today, 05:10 PM

Price Summary

Today's High

₹ 1048.15

Today's Low

₹ 948.35

52 Week High

₹ 1117

52 Week Low

₹ 0

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

984.03 Cr.

Enterprise Value

1020.12 Cr.

No. of Shares

1.04 Cr.

P/E

63.84

P/B

15.95

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  59.47

CASH

5.13 Cr.

DEBT

41.23 Cr.

Promoter Holding

54.24 %

EPS (TTM)

₹  14.86

Sales Growth

88.56%

ROE

28.55 %

ROCE

26.52%

Profit Growth

82.83 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year88.56%
3 Year24.1%
5 Year28.08%

Profit Growth

1 Year82.83%
3 Year48.83%
5 Year52.24%

ROE%

1 Year28.55%
3 Year23.59%
5 Year20.42%

ROCE %

1 Year26.52%
3 Year22.19%
5 Year21.11%

Debt/Equity

0.6681

Price to Cash Flow

37.34

Interest Cover Ratio

9.30885043451746

CFO/PAT (5 Yr. Avg.)

1.2370015642164

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2021 54.24 0
Mar 2021 54.13 0
Sep 2020 51.52 0
Mar 2020 51.52 0
Sep 2019 50.14 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 24.0986264994319% for the Past 3 years.
  • Company has been maintaining healthy ROE of 23.5878130114204% over the past 3 years.
  • Company has been maintaining healthy ROCE of 22.1885132845545% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 9.30885043451746.
  • Company’s PEG ratio is 0.770718069805166.
  • The company has an efficient Cash Conversion Cycle of 35.8516247465331 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.2370015642164.
  • The company has a high promoter holding of 54.24%.

 Limitations

  • The company is trading at a high EV/EBITDA of 33.0577.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 95.32 136.83 165.15 138.68 261.5
Total Expenditure 86.75 125.33 149.9 124.55 232.23
Operating Profit 8.57 11.5 15.25 14.14 29.27
Other Income 1.52 1.1 0.93 3.92 1.59
Interest 1.91 2.19 2.22 2.52 2.62
Depreciation 2.37 2.86 3.06 4.39 6.44
Exceptional Items 0 0 0 0 0
Profit Before Tax 5.81 7.55 10.9 11.14 21.8
Tax 2.37 2.87 3.35 2.71 6.38
Net Profit 3.44 4.68 7.55 8.43 15.42
Adjusted EPS (Rs.) 3.31 4.51 7.27 8.13 14.86

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 5.19 10.38 10.38 10.38 10.38
Total Reserves 21.25 20.74 28.29 36.72 52.13
Borrowings 3.13 4.11 7.01 10.18 18.26
Other N/C liabilities 0.94 0.76 0.64 9.6 9.82
Current liabilities 41.52 61.7 60.67 67.61 78.15
Total Liabilities 72.03 97.69 106.99 134.48 168.75
Assets
Net Block 15.77 19.27 28.02 41.63 58.41
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 3.73 4.11 4.64 4.2 4.28
Loans & Advances 0.12 0.12 0.12 0.12 0.17
Other N/C Assets 0.1 0.07 0.03 0 0
Current Assets 52.31 74.12 74.17 88.53 105.88
Total Assets 72.03 97.69 106.99 134.48 168.75
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 5.81 7.55 10.9 11.14 21.8
Adjustment 4.15 4.61 4.74 6.27 8.98
Changes in Assets & Liabilities -3.53 -9.2 0.76 -9.06 1.96
Tax Paid -2.42 -3.06 -3.44 -2.71 -6.38
Operating Cash Flow 4.01 -0.09 12.96 5.63 26.36
Investing Cash Flow -7.25 -6.2 -11.8 -17.13 -23.2
Financing Cash Flow 4.6 4.96 -1.91 12.36 0.83
Net Cash Flow 1.36 -1.33 -0.75 0.87 3.99

Corporate Actions

Investors Details

PARTICULARS Sep 2019% Mar 2020% Sep 2020% Mar 2021% Sep 2021%
Promoters 50.14 51.52 51.52 54.13 54.24
ramesh arora 30.86 28.58 28.58 28.58 28.58
ajay arora 13.45 13.45 13.45 13.45 13.45
aditya arora 6.41 1.37 1.37 1.37 1.37
anu mehra - 2.32 2.32 2.32 2.32
anju arora 1.31 1.31 1.31 1.31 1.31
geeta arora 1.07 1.07 1.07 1.07 1.07
aarti bajaj - 0.90 - 0.90 0.90
aarti bajaj - - 0.90 - -
jugal kishore huf 0.89 0.89 0.89 0.89 0.89
sachin seth 0.25 0.25 0.25 0.25 0.25
PARTICULARS Sep 2019% Mar 2020% Sep 2020% Mar 2021% Sep 2021%
Investors 49.86 48.48 48.48 45.87 45.76
t r metals private... - 13.31 13.31 13.31 13.31
rkk portfolio priv... 12.56 - - - -
deepak bansal 10.54 - - - 5.92
guiness securities... - 6.16 5.87 - -
ways vinimay priva... - - - 5.44 5.44
jani bhasha shaik 1.45 - - 1.82 1.82
nizamuddin shaik 1.16 - 1.16 1.39 1.39
ashish kacholia 1.36 - - - -
neeraj jain - 1.16 1.16 - -
ashok lakhani - 1.04 1.04 1.04 1.04
onkar singh 1.01 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Kwality Pharma Stock Price Analysis and Quick Research Report. Is Kwality Pharma an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Kwality Pharma and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 26.3559 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Kwality Pharma has a Debt to Equity ratio of 0.6681 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Kwality Pharma , the EPS growth was 82.8263061139774 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Kwality Pharma has OPM of 11.1934599528035 % which is a bad sign for profitability.
     
  • ROE: Kwality Pharma have a healthy ROE of 28.5450276284017 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Kwality Pharma

X